GATA-3 significantly downregulates IFN-γ production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels

Clinical Immunology

Volumn 91, Issue 2, 1999, Pages 134-144

  Ferber, Iris A ^a   Lee, Hyun Jun ^a   Zonin, Francesca ^a   Heath, Victoria ^a   Mui, Alice ^a   Arai, Naoko ^a   O'Garra, Anne ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CD4+ T cells; DO11.10 transgenic mice; Retroviral transduction; T cell subset development; Zinc finger transcription factor

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; DRUG EFFECT; EFFECTOR CELL; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; RECEPTOR DOWN REGULATION; RETROVIRUS; T LYMPHOCYTE ACTIVATION; VIRUS INDUCTION; VIRUS INFECTION;

EID: 0032906187     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4718     Document Type: Article

References (52)

1. HH. Immunol. Today. 12:1991;256-257.
2. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. J. Immunol. 136:1986;2348-2357.
3. Sher A., Coffman R. L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Ann. Rev. Immunol. 10:1992;385-409.
4. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
5. Fitch F. W., McKisic M. D., Lancki D. W., Gajewski T. F. Differential regulation of murine T lymphocyte subsets. Ann. Rev. Immunol. 11:1993;29-48.
6. Moore K. W., O'Garra A., Malefyt R. d. W., Vieira P., Mosmann T. R. Interleukin-10. Ann. Rev. Immunol. 11:1993;165-190.
7. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
8. Abehsira-Amar O., Gibert M., Joliy M., Theze J., Jankovic D. L. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol. 148:1992;3820-3829.
9. Rocken M., Muller K. M., Saurat J-H., Muller I., Louis J. A., Cerottini J-c., Hauser C. Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward a Th1 or Th2 functional phenotype. J. Immunol. 148:1992;47-54.
10. Kamogawa Y., Minasi L.-a. E., Carding S. R., Bottomly K., Flavell R. A. The relationship of IL-4 and IFN-γ-producing T cells studied by lineage ablation of IL-4 producing cells. Cell. 75:1993;985-995.
11. Swain S. L., Weinberg A. D., English M., Huston G. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:1990;3796-3806.
12. Le Gros G., Ben-Sasson S., Seder R., Finkelman F. D., Paul W. E. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172:1990;921-929.
13. Hsieh C-S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of Th1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science. 260:1993;547-549.
14. Paul W. E., Seder R. A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
15. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13:1995;251-276.
16. Ho I-C., Hodge M. R., Rooney J. W., Glimcher L. H. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 85:1996;973-983.
17. Rooney J. W., Hoey T., Glimcher L. H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity. 2:1995;473-483.
18. Kaplan M., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:1996;313-319.
19. Rincon M. a. F. R. Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell. Biol. 17:1997;1522-1534.
20. Davydov I. V., Krammer P. H., Li-Weber M. Nuclear factor-IL-6 activates the human IL-4 promoter in T cells. J. Immunol. 155:1995;5273-5279.
21. Ting C. N., Olson M. C., Barton K. P., Leiden J. M. Transcription factor GATA-3 is required for development of the T cell lineage. Nature. 384:1996;474-478.
22. Pandolfi P. P., Roth M. E., Karis A., Leonard M. W., Dzierzak E., Grosweld F. G., Engel J. D., Lindenbaum M. H. Targeted disruption of the GATA-3 gene causes severe abnormalities in the nervous system and in fetal liver hematopoiesis. Nat. Genet. 11:1995;40-44.
23. Zheng W-P., Flavell R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:1997;587-596.
24. ++. Science. 250:1990;1720-1722.
25. Haskins K., Kobo R., White J., Pigeon M., Kappler J., Marrack P. The MHC-restricted antigen on T cells. J. Exp. Med. 157:1983;1149-1169.
26. Kuhn R., Rajewsky K., Muller W. Generation and analysis of interleukin-4 deficient mice. Science. 254:1991;707-710.
27. Schoenhaut D. S., Chua A. O., Wolitzky A. G., Quinn P. M., Dwyer C. M., McComas W., Familletti P. C., Gately M. K., Gubler U. Cloning and expression of IL-12. J. Immunol. 148:1992;3433-3440.
28. Ohara J., Paul W. E. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature. 315:1985;333-336.
29. Abrams J. Immunometric assay of mouse and human cytokines using NIP-labelled anti-cytokine antibodies. Curr. Protoc. Immunol. 13:1995;6.1-15.
30. Ozmen L., Pericin M., Hakimi J., Chizzonite R. A., Wysocka M., Trinchieri G., Gately M., Garotta G. Interleukin 12, interferon-γ, and tumor necrosis factor-α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med. 180:1994;907-915.
31. Openshaw P., Murphy E., Hosken N. A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1995;1357-1367.
32. +. Int. Immunol. 5:1993;1119-1128.
33. Yang Z., Gu L., Romeo P. H., Bories D., Motohashi H., Yamamoto M., Engel J. D. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol. Cell. Biol. 14:1994;2201-2212.
34. Heemskerk M. H. M., Blom B., Nolan G., Stegmann A. P. A., Bakker A. Q., Weijer K., Res P. C. M., Spits H. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor ld3. J. Exp. Med. 186:1997;1597-1602.
35. Kinsella T. M., Nolan G. P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1996;1405-1413.
36. Staal F. J. T., Bakker A. Q., Verkuylen M., van Oort E., Spits H. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: A method to select producer cells and follow transduced target cells. Cancer Gene Ther. 3:1996;345-351.
37. Onishi M., Mui A. L., Morikawa Y., Cho L., Kinoshita S., Nolan G. P., Gorman D. M., Miyajima A., Kitamura T. Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood. 88:1996;1399-1406.
38. Ko L. J., Yamamoto M., Leonard M. W., George K. M., Ting P., Engel J. D. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol. Cell. Biol. 11:1991;2778-2784.
39. --. J. Exp. Med. 174:1991;547-559.
40. Murphy E., Shibuya K., Hosken N., Openshaw P., Maino V., Davis K., Murphy K., O'Garra A. Reversibility of T Helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:1996;901-913.
41. Slade S. J., Langhorne J. Production of interferon-gamma during infection of mice with plasmodium chabaudi chabaudi. Immunobiology. 179:1989;353-365.
42. Masuda E. S., Tokumitsu H., Tsuboi A., Shlomai J., Hung P., Arai K., Arai N. The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT. Mol. Cell. Biol. 13:1993;7399-7407.
43. Ouyang W., Ranganath S., Weindel K., Bhattacharya D., Murphy T. L., Sha W. C., Murphy K. M. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 9:1998;745-755.
44. Zhang D. H., Cohn L., Ray P., Bottomly K., Ray A. Transcription factor GATA-3 is differentially expressed in Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:1997;21597-21562.
45. Lee H-J., O'Garra A., Arai K-I., Arai N. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: A role for a GATA-binding protein. J. Immunol. 160:1998;2343-2347.
46. Zhang D. H., Yang L., Ray A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161:1998;3817-3821.
47. Ranganath S., Ouyang W., Bhattarcharya D., Sha W., Grupe A., Peltz G., Murphy K. M. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:1998;3822-3826.
48. Penix L., Weaver W. M., Pang Y., Wilson C. B. Two essential regulatory elements in the human interferon-γ promoter confer activation specific expression in T cells. J. Exp. Med. 178:1993;1483-1496.
49. Young H. A. Regulation of interferon-γ expression. J. Interferon Cytokine Res. 16:1996;563-568.
50. Magram J., Connaughton S. E., Warrier R. R., Carvajal D. M., Wu C., Ferrante J., Stewart C., Sarmiento U., Faherty D. A., Gately M. K. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity. 4:1996;471-481.
51. Szabo S., Dighe A., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
52. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D. H., Gubler U., Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825-831.